•
Jun 30, 2024

Immix Biopharma Q2 2024 Earnings Report

EPS
-$0.15
Previous year: -$0.24
-37.5%
Gross Profit
-$24.3K
Cash and Equivalents
$24M
Previous year: $12.7M
+89.5%
Free Cash Flow
-$5.35M
Total Assets
$28.8M
Previous year: $15.6M
+85.2%

Immix Biopharma

Immix Biopharma